VGXI Blog & News
Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments NASHVILLE, Tenn. and CONROE, Texas, Oct. 15, 2024 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”), a global leader in supply chain[…]
Read More
VGXI to Attend Alliance for Regenerative Medicine Annual Meeting on the Mesa
Conroe, Texas – VGXI, Inc., a leading provider of plasmid DNA manufacturing and development[…]
Read More
VGXI accepted as a Member of the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
VGXI, accepted as a Member of the US Government’s Rapid Response Partnership Vehicle (RRPV)
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
Future Proof Your Advanced Therapies Supply Chain with VGXI’s US-Based Plasmid CDMO Expertise
In the current landscape of biopharmaceutical drug development, finding a reliable and[…]
Read More
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
VGXI’s Expanded Manufacturing Capacity Addresses Plasmid DNA Supply Chain Challenges
Plasmid DNA (pDNA) is an essential part of the supply chain for advanced therapies and[…]
Read More
Five Qualities to Look for in a CDMO
As the biopharmaceutical industry increasingly turns to outsourcing, the key to success lies in[…]
Read More
Stephanie Burke Named as VGXI’s New Chief Accounting Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new[…]
Read More
VGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization
Plasmids are small, circular, double-stranded DNA molecules that have become indispensable[…]
Read More